BioSpace News Archive

MedSurvey, a leading medical market research company, is proud to announce that it has been recognized as a 2018 Inc. 5000 company, marking its first appearance on the most prestigious list of the nation’s fastest growing private companies.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today announced the appointment of industry leader, Jeb Keiper, as an independent member of its Board of Directors.

iSchemaView, the leader in cerebrovascular imaging analysis, today announced it has received final approval for the use of the RAPID platform in Canada.

The expectations are that direct streaming will become available to hearing aid users of the recently launched hearing aids ReSound LiNX Quattro™ and Beltone Amaze™ in a future Android release.

Henderson, 53, is the non-executive chairman of the board of Qualcomm, Inc. and serves on the board of directors at FibroGen, Inc. and Halozyme Therapeutics, Inc. as well as serving as an advisory director to Berkshire Partners LLC.

Sir Andrew Witty spent over three decades at GlaxoSmithKline, most recently serving as CEO from 2008 to 2017.

This prestigious list of the nation’s most successful private companies has become the hallmark of entrepreneurial success and the place where future household names first make their mark.

New Data Used to Support Successful Belgian Reimbursement

Nurx offers at-home lab testing to expand access to PrEP and combat escalating HIV rates

Michael Goldberg, M.D. Resigns as Chief Executive Officer and Director of Navidea